An2 Therapeutics Closed $80 Million Series B Financing To Advance Novel Nontuberculous Mycobacterial Lung Disease Program
Amount Raised
$80 Million
Round Type
Series B
Menlo ParkBiotechnologyHealth CareScience And EngineeringDescription
AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing treatments for rare, chronic, and serious infectious diseases with high unmet medical need, today announced several significant strides in the company's development over the past year.
Quick answer
AN2 Therapeutics raised $80 Million in a Series B round, dated January 7, 2022. AN2 Therapeutics is based in Menlo Park, California, United States.
- How much did AN2 Therapeutics raise?
- AN2 Therapeutics raised $80 Million in a Series B round on January 7, 2022.
- What does AN2 Therapeutics do?
- AN2 Therapeutics, Inc. is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform.
- Where is AN2 Therapeutics based and how big is it?
- AN2 Therapeutics is based in Menlo Park, California, United States. Fundz records about 36 employees.
- Who are the decision-makers at AN2 Therapeutics?
- Fundz holds 1 contact at AN2 Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Science And Engineering and Biotechnology around the same time
Companies in the same sectors as AN2 Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Synthego Corp raised $200M (Funding Round) on February 17, 2022.
- Electra Therapeutics raised $84M (Series B) on February 16, 2022.
- Walking Fish Therapeutics raised $73M (Series A) on February 16, 2022.
- Memo Therapeutics AG raised an undisclosed amount (Series B) on February 16, 2022.
- Variantyx raised $42M (Funding Round) on February 14, 2022.
- Arkuda Therapeutics raised $64M (Series B) on February 10, 2022.
Who to call at AN2 Therapeutics, and when
A new round usually means AN2 Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day AN2 Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at AN2 Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at AN2 Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment AN2 Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansAN2 Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.